av/iol-chemicals-and-phar--big.svg

COM:IOLCP

IOL Chemicals and Pharmaceuticals Limited

  • Stock

Last Close

393.30

12/11 09:59

Market Cap

24.69B

Beta: -

Volume Today

66.56K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
1.78B
-
2.03B
14.04%
2.21B
8.81%
2.45B
11.15%
2.35B
4.18%
1.98B
15.69%
1.88B
5.03%
2.41B
28.24%
3.53B
46.07%
3.68B
4.31%
average payables
1.04B
-
918.11M
12.04%
934.36M
1.77%
1.35B
44.72%
1.43B
5.91%
1.26B
11.71%
1.53B
21.15%
2.12B
38.70%
3.24B
52.53%
3.62B
11.63%
average receivables
938.05M
-
938.05M
0%
1.82B
-
4.40B
142.11%
5.12B
16.37%
book value per share
76.86
-
51.98
32.38%
35.15
32.38%
33.69
4.14%
38.38
13.93%
84.39
119.85%
143.01
69.46%
216.08
51.10%
237.20
9.77%
256.81
8.27%
capex per share
-5.02
-
-1.48
70.45%
-5.06
241.61%
-3.99
21.22%
-8.60
115.71%
-10.77
25.16%
-14.11
31.05%
-18.55
31.46%
-26.11
40.75%
-36.08
38.17%
capex to depreciation
-0.43
-
-0.20
52.66%
-0.90
339.59%
-0.75
16.67%
-1.60
113.83%
-1.87
17.10%
-2.25
19.86%
-2.78
23.74%
-3.54
27.45%
-4.59
29.50%
capex to operating cash flow
-0.17
-
0.13
171.91%
-1.51
1,297.59%
-0.29
80.90%
-0.40
40.33%
-0.22
45.14%
-0.17
23.09%
-0.28
67.20%
-1.65
478.18%
-1.73
5.16%
capex to revenue
-0.02
-
-0.02
36.63%
-0.05
199.20%
-0.03
31.35%
-0.05
59.32%
-0.04
27.24%
-0.04
17.79%
-0.06
29.07%
-0.07
27.14%
-0.10
35.14%
cash per share
4.20
-
3.19
24.17%
2.27
28.66%
2.93
28.58%
0.14
95.13%
2.40
1,583.64%
22.99
859.54%
57.71
150.97%
20.45
64.56%
7.97
61.05%
days of inventory on hand
189.67
-
278.98
47.09%
201.16
27.90%
195.29
2.92%
106.42
45.51%
64.61
39.29%
63.10
2.33%
95.83
51.86%
93.70
2.22%
76.80
18.04%
days payables outstanding
111.87
-
91.83
17.91%
102.92
12.08%
114.38
11.14%
68.02
40.53%
41.14
39.51%
62.62
52.20%
77.54
23.83%
93.56
20.66%
74.13
20.77%
days sales outstanding
71.17
-
68.10
-
86.86
27.54%
83.47
3.90%
debt to assets
0.42
-
0.57
34.17%
0.58
3.08%
0.55
6.35%
0.51
6.13%
0.30
41.27%
0.05
83.22%
0.00
96.65%
0.02
1,220.93%
0.04
76.22%
debt to equity
1.50
-
1.92
28.28%
2.45
27.58%
2.36
3.46%
1.96
17.25%
0.60
69.38%
0.07
87.79%
0.00
97.04%
0.03
1,357.22%
0.05
67.71%
dividend yield
0.02
-
0.01
64.45%
0.02
132.12%
0.01
16.57%
earnings yield
0.06
-
-0.58
1,088.85%
-0.10
82.99%
0.01
112.01%
0.06
410.17%
0.21
245.15%
0.36
71.61%
0.14
61.68%
0.08
41.64%
0.08
3.76%
enterprise value
3.57B
-
4.99B
39.61%
8.44B
69.12%
7.85B
6.97%
8.76B
11.55%
13.96B
59.40%
10.32B
26.05%
31.84B
208.47%
21.17B
33.51%
17.39B
17.85%
enterprise value over ebitda
3.73
-
66.12
1,671.47%
23.03
65.17%
9.12
60.39%
7.23
20.70%
3.36
53.53%
1.76
47.51%
5.21
195.17%
7.41
42.36%
6.92
6.65%
ev to operating cash flow
4.58
-
-10.62
332.03%
47.66
548.69%
10.08
78.86%
7.31
27.42%
5.11
30.14%
2.19
57.12%
8.38
282.63%
22.75
171.39%
14.22
37.48%
ev to sales
0.63
-
1.30
104.48%
1.45
12.10%
1.10
24.02%
0.91
17.60%
0.84
7.34%
0.55
34.32%
1.64
195.37%
0.98
40.32%
0.78
19.65%
free cash flow per share
23.65
-
-13.26
156.07%
-1.70
87.16%
9.87
679.42%
12.70
28.65%
37.83
197.96%
68.70
81.60%
46.56
32.23%
-10.26
122.04%
-15.25
48.65%
free cash flow yield
1.15
-
-0.46
140.19%
-0.02
95.19%
0.16
803.22%
0.16
0.17%
0.19
20.36%
0.39
106.63%
0.08
78.36%
-0.03
134.33%
-0.05
85.88%
graham net net
-155.85
-
-94.07
39.64%
-88.24
6.20%
-85.58
3.02%
-64.18
25.01%
-63.98
0.30%
-24.16
62.24%
69.75
388.68%
24.22
65.28%
12.84
46.98%
graham number
45.78
-
139.83
205.44%
77.52
44.56%
23.88
69.20%
65.24
173.23%
282.77
333.42%
452.06
59.87%
608.72
34.66%
390.42
35.86%
370.06
5.22%
income quality
23.66
-
0.70
97.02%
-0.46
165.17%
14.22
3,197.05%
3.82
73.10%
0.81
78.75%
0.88
8.71%
0.66
24.77%
0.41
37.74%
0.65
56.62%
intangibles to total assets
0.00
-
0.00
22.84%
0.00
200.03%
0.00
9.02%
0.00
6.35%
0.00
35.44%
0.00
44.78%
0.00
12.67%
0.00
377.51%
0.00
143.01%
interest coverage
-1.39
-
-0.85
39.16%
0.11
112.82%
1.54
1,315.96%
8.21
433.15%
34.31
317.89%
608.96
1,675.01%
99.70
83.63%
12.45
87.51%
interest debt per share
114.96
-
113.29
1.45%
94.65
16.45%
88.57
6.43%
85.56
3.40%
58.82
31.25%
13.27
77.44%
0.63
95.26%
7.90
1,155.69%
16.40
107.58%
inventory turnover
1.92
-
1.31
32.01%
1.81
38.69%
1.87
3.00%
3.43
83.51%
5.65
64.71%
5.78
2.39%
3.81
34.15%
3.90
2.27%
4.75
22.01%
invested capital
1.50
-
1.92
28.28%
2.45
27.58%
2.36
3.46%
1.96
17.25%
0.60
69.38%
0.07
87.79%
0.00
97.04%
0.03
1,357.22%
0.05
67.71%
market cap
558.09M
-
1.14B
104.28%
4.02B
252.98%
3.54B
12.08%
4.54B
28.44%
11.25B
147.57%
10.01B
11.06%
32.13B
221.10%
20.76B
35.38%
16.61B
20.03%
net current asset value
-2.51B
-
-2.11B
16.01%
-2.31B
9.28%
-2.16B
6.22%
-2.10B
2.95%
205.20M
109.78%
3.09B
1,405.46%
6.73B
117.74%
5.11B
24.03%
4.06B
20.55%
net debt to ebitda
3.15
-
51.01
1,519.56%
12.04
76.39%
5.01
58.41%
3.48
30.55%
0.65
81.27%
0.05
91.76%
-0.05
190.23%
0.14
392.05%
0.31
120.63%
net income per share
1.21
-
-16.72
1,479.57%
-7.60
54.55%
0.75
109.90%
4.93
555.23%
42.11
754.46%
63.51
50.82%
76.21
20.00%
28.56
62.52%
23.70
17.02%
operating cash flow per share
28.67
-
-11.78
141.09%
3.36
128.52%
13.86
312.40%
21.30
53.71%
48.60
128.16%
82.81
70.40%
65.11
21.38%
15.85
75.66%
20.83
31.39%
payables turnover
3.26
-
3.97
21.82%
3.55
10.78%
3.19
10.02%
5.37
68.15%
8.87
65.33%
5.83
34.30%
4.71
19.24%
3.90
17.12%
4.92
26.21%
receivables turnover
5.13
-
5.36
-
4.20
21.59%
4.37
4.05%
research and ddevelopement to revenue
return on tangible assets
0.00
-
-0.10
2,233.96%
-0.05
45.65%
0.01
110.02%
0.03
552.42%
0.25
645.14%
0.31
22.25%
0.28
10.17%
0.09
69.01%
0.07
19.26%
revenue per share
206.99
-
96.51
53.37%
110.19
14.17%
126.44
14.75%
171.18
35.39%
294.44
72.00%
327.58
11.25%
333.64
1.85%
369.36
10.71%
377.64
2.24%
roe
0.02
-
-0.32
2,140.06%
-0.22
32.79%
0.02
110.33%
0.13
475.10%
0.50
288.65%
0.44
11.00%
0.35
20.58%
0.12
65.86%
0.09
23.36%
roic
0.01
-
-0.11
1,844.42%
-0.06
43.10%
0.01
110.59%
0.13
1,799.43%
0.36
182.02%
0.42
19.39%
0.35
17.13%
0.13
64.28%
0.10
24.18%
sales general and administrative to revenue
0.00
-
0.00
6.62%
0.00
19.85%
0.00
15.96%
0.00
48.43%
0.00
58.94%
0.00
0.28%
0.00
26.71%
shareholders equity per share
76.86
-
51.98
32.38%
35.15
32.38%
33.69
4.14%
38.38
13.93%
84.39
119.85%
143.01
69.46%
216.08
51.10%
237.20
9.77%
256.81
8.27%
stock based compensation to revenue
tangible asset value
2.09B
-
2.07B
1.00%
1.84B
11.00%
1.88B
2.32%
2.15B
13.97%
4.74B
120.55%
8.13B
71.67%
12.60B
54.95%
13.89B
10.25%
14.99B
7.91%
tangible book value per share
76.86
-
51.98
32.38%
35.15
32.38%
33.69
4.14%
38.21
13.40%
84.26
120.53%
142.92
69.62%
215.98
51.12%
236.59
9.54%
255.30
7.91%
working capital
113.33M
-
749.47M
561.31%
763.76M
1.91%
859.64M
12.55%
819.90M
4.62%
2.31B
181.95%
3.89B
68.12%
7.32B
88.28%
5.67B
22.46%
4.64B
18.20%

All numbers in (except ratios and percentages)